Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2005
10/11/2005US6953774 Administration of a non-polypeptide cAMP level modulator to host
10/11/2005US6953679 Biosynthesis with enzyme or microorganism, catalyzing hydroxylation reaction, useful as modulators of nuclear hormone receptor, anticarcinogenic agents, immunomodulators, steroid mimic
10/11/2005US6953670 Methods for identifying compounds capable of supplementing the biological activity of leptin
10/11/2005US6953595 Inhibitors of apoptosis of nerve cells
10/11/2005US6953591 Administering to a mammal non-toxic effective T-cell function-mediated disorder-treating amount of phosphatidyl serine (PS) carrying bodies wherein progression of T-cell function-mediated disorder is inhibited
10/11/2005US6953590 Tape material for transcutaneous absorption
10/11/2005US6953588 Comprised of vitamins A, C, D, E, K, B1, B2, niacinamide, vitamin B6, vitamin B12, biotin, pantothenic acid, iron, iodine, magnesium, zinc, selenium, copper, chromium, potassium, choline, lycopene, coenzyme q-10
10/11/2005US6953586 Bioabsorbable and biocompatible grafts for administered under the skin of animals comprising solid pellets having animal growth regulators such as trenbolone acetate and melengesterol acetate
10/11/2005US6953583 Use of conjugated linoleic acid (CLA) for the topical treatment of cellulite
10/11/2005US6953580 Plant extracts; viricides, blood flow, alopecia
10/11/2005US6953578 Administering a prostaglandin-2 synthase inhibitor selected from indomethacin, animoguanadine or N-(2-(cyclohexyloxy)-4-nitrophenyl)methanesulfonamide for preventing or reducing severity of autoimmune disease
10/11/2005US6953575 Methods of treating central nervous system disorders using viral vectors
10/11/2005US6953571 Cosmetic or pharmaceutical composition for topical use to prevent or differ androgenetic alopecia
10/11/2005US6953568 Administering biological conjugates that bind preferentially to endothelial protein C receptor(EPCR), to endothelial cells of vascular systems; genetic translocation; drug delivery
10/11/2005CA2373794C Compositions and uses of et743 for treating cancer
10/11/2005CA2358773C Improved controlled release compositions and method
10/11/2005CA2341949C Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses
10/11/2005CA2315818C Water-soluble eye drop
10/11/2005CA2282277C Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
10/11/2005CA2275596C Method for the crystallisation of a tetrahydropyridin derivative and resulting crystalline forms
10/08/2005CA2503754A1 Composition and method to prevent or reduce diarrhea and steatorrhea in hiv patients
10/07/2005CA2504404A1 Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
10/06/2005WO2005093422A2 Carbohydrate-encapsulated quantum dots for biological imaging
10/06/2005WO2005093090A1 Antisense oligonucleotides and uses thereof in improving cancer treatment strategies
10/06/2005WO2005093083A1 Method of disease prediction and method of using the same
10/06/2005WO2005093067A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005WO2005093064A1 Novel galectin 9 modification protein and use thereof
10/06/2005WO2005093027A1 Compositions with health and nutrition promoting characteristics, containing interestified lipids and phytosterol, and related methods
10/06/2005WO2005092934A1 Orthoester-protected polyols for low voc coatings
10/06/2005WO2005092908A1 Base addition salts of monosaccharides derivatives as inhibitors of airway hyper reactivity and airway inflammation
10/06/2005WO2005092907A2 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents
10/06/2005WO2005092904A1 Novel compounds for modulating cell proliferation
10/06/2005WO2005092902A1 Process for producing folic acid derivative
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092898A1 The conjugates of a hydrophilic polymer-tripterygium's extracts and the pharmaceutical compositions thereof
10/06/2005WO2005092895A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
10/06/2005WO2005092894A1 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
10/06/2005WO2005092893A1 9-substituted 8-oxoadenine compound
10/06/2005WO2005092892A1 8-oxoadenine compound
10/06/2005WO2005092890A2 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
10/06/2005WO2005092889A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof
10/06/2005WO2005092886A1 Process for the preparation of amorphous form of tiagabine
10/06/2005WO2005092885A1 4-amino-piperidine derivatives as monoamine uptake inhibitors
10/06/2005WO2005092884A1 Novel crystalline forms of conazoles and methods of making and using the same
10/06/2005WO2005092882A1 4-amino-5-halogeno-benzamide derivatives as 5-ht4 receptor agonists for the treatment of gastrointestinal, cns, neurological and cardiovascular disorders
10/06/2005WO2005092880A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
10/06/2005WO2005092877A1 Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
10/06/2005WO2005092875A1 Crystalline citalopram diol intermediate alkali
10/06/2005WO2005092864A1 Imidazole compounds for the treatment of neurodegenerative disorders
10/06/2005WO2005092863A1 4-carbox pyrazole derivates useful as anti-viral agents
10/06/2005WO2005092860A1 Compounds for the treatment of diseases
10/06/2005WO2005092858A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
10/06/2005WO2005092856A1 Tetrahydrocarbazoles and derivatives
10/06/2005WO2005092852A1 Process for the production of atorvastatin calcium in amorphous form
10/06/2005WO2005092850A1 Amino acid and peptide conjugates of arylalkylic acids for cosmetic use
10/06/2005WO2005092843A1 Novel urea derivatives and their medical use
10/06/2005WO2005092840A1 Formamide derivatives useful as adrenoceptor
10/06/2005WO2005092442A2 Method and compositions for treatment of chronic neuropathic pain
10/06/2005WO2005092441A2 Extended cycle multiphasic oral contraceptive method
10/06/2005WO2005092394A1 siRNA CAPABLE OF INHIBITING EXPRESSION OF WT1 GENE AND USE THEREOF
10/06/2005WO2005092393A1 Micro rna inhibiting the expression of wt1 gene and utilization of the same
10/06/2005WO2005092392A2 Conjugated psychotropic drugs and uses thereof
10/06/2005WO2005092389A1 Composite particle and coated composite particle
10/06/2005WO2005092388A1 Liposome preparation
10/06/2005WO2005092387A1 Stable injectable diclofenac compositions
10/06/2005WO2005092386A1 Clear, stable topical compositions of clarithromycin and processes for their preparation
10/06/2005WO2005092385A2 Combination therapy of azd2171 and a taxane
10/06/2005WO2005092384A2 Combination therapy with azd2171 and a platinum anti-tumour agent
10/06/2005WO2005092383A1 Preventive/remedy for respiratory diseases
10/06/2005WO2005092382A1 Therapeutic agent for diabetes containing insulin resistance improving agent
10/06/2005WO2005092370A1 Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
10/06/2005WO2005092364A1 Topical glutathione treatments
10/06/2005WO2005092362A2 Pharmaceutical combined preparation containing a therapeutic protein
10/06/2005WO2005092358A1 Oral health care drink and method for reducing malodors
10/06/2005WO2005092350A1 Preparation of polymerizable compositions
10/06/2005WO2005092349A1 Insulin resistance improving agent
10/06/2005WO2005092348A1 Hgf production accelerator containing heparin-like oligosaccharide
10/06/2005WO2005092347A2 Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
10/06/2005WO2005092346A1 Using combination of estrogen and progestin with ultra low dose for long term oral contraception
10/06/2005WO2005092345A1 Use of a phenothiazine derivative for preventing and/or treating hearing loss
10/06/2005WO2005092344A1 Medicinal preparation
10/06/2005WO2005092343A1 Use of pde iii inhibitors for the reduction of heart size in mammals suffering from heart failure
10/06/2005WO2005092342A1 Combination therapy for lower urinary tract symptoms
10/06/2005WO2005092341A1 Combination therapy for lower urinary tract symptoms
10/06/2005WO2005092340A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain
10/06/2005WO2005092339A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders
10/06/2005WO2005092337A1 6 α-OXYMORPHOL AND A METHOD OF USE
10/06/2005WO2005092336A1 Controlled-leaching preparation and process for producing the same
10/06/2005WO2005092335A1 TETRAHYDRO-β-CARBOLINE COMPOUNDS AND USE THEREOF
10/06/2005WO2005092334A2 Use of n-substituted imino sugars for appetite suppression
10/06/2005WO2005092333A1 (r)-enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005WO2005092332A1 (s) - enoximone sulfoxide and its use in the treatment of pde-iii mediated diseases
10/06/2005WO2005092331A1 Use of rotigotine for treating and preventing parkinson's plus syndrome
10/06/2005WO2005092330A1 Medicament or dietary agent for oral administration containing blueberry extract and antioxidants and micronutrients
10/06/2005WO2005092329A1 Topical and intravaginal microbicidal antiparasitic compositions comprising quassinoids or quassinoid-containing plant extracts
10/06/2005WO2005092328A1 Fxr activation compound
10/06/2005WO2005092327A1 Periodontal ligament-protecting agent
10/06/2005WO2005092326A1 Small molecule antagonists of xiap family proteins
10/06/2005WO2005092325A1 Use of a serine palmitoyltransferase (spt) inhibitor to treat atherosclerosis and dyslipidemia
10/06/2005WO2005092324A1 Ginkgolide compounds, compositions, extracts, and uses thereof
1 ... 4512 4513 4514 4515 4516 4517 4518 4519 4520 4521 4522 4523 4524 4525 4526 4527 4528 4529 4530 4531 4532 ... 7860